PRO 2000 Completed Phase 2 Trials for Human Immunodeficiency Virus (HIV) Infections Prevention
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Prevention | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00074425 | BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women |